Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jun 12:365:l1945.
doi: 10.1136/bmj.l1945.

Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data

Robert Haase  1 Peter Schlattmann  2 Pascal Gueret  3 Daniele Andreini  4 Gianluca Pontone  5 Hatem Alkadhi  6 Jörg Hausleiter  7 Mario J Garcia  8 Sebastian Leschka  9 Willem B Meijboom  10 Elke Zimmermann  1 Bernhard Gerber  11 U Joseph Schoepf  12 Abbas A Shabestari  13 Bjarne L Nørgaard  14 Matthijs F L Meijs  15 Akira Sato  16 Kristian A Ovrehus  17 Axel C P Diederichsen  18 Shona M M Jenkins  18 Juhani Knuuti  19 Ashraf Hamdan  20 Bjørn A Halvorsen  21 Vladimir Mendoza-Rodriguez  22 Carlos E Rochitte  23 Johannes Rixe  24 Yung Liang Wan  25 Christoph Langer  26 Nuno Bettencourt  27 Eugenio Martuscelli  28 Said Ghostine  29 Ronny R Buechel  30 Konstantin Nikolaou  31 Hans Mickley  17 Lin Yang  32 Zhaqoi Zhang  32 Marcus Y Chen  33 David A Halon  34 Matthias Rief  1 Kai Sun  35 Beatrice Hirt-Moch  31 Hiroyuki Niinuma  36 Roy P Marcus  17 Simone Muraglia  37 Réda Jakamy  38 Benjamin J Chow  39 Philipp A Kaufmann  31 Jean-Claude Tardif  40 Cesar Nomura  41 Klaus F Kofoed  42 Jean-Pierre Laissy  43 Armin Arbab-Zadeh  44 Kakuya Kitagawa  45 Roger Laham  46 Masahiro Jinzaki  47 John Hoe  48 Frank J Rybicki  49 Arthur Scholte  50 Narinder Paul  51 Swee Y Tan  52 Kunihiro Yoshioka  53 Robert Röhle  1 Georg M Schuetz  1 Sabine Schueler  1 Maria H Coenen  1 Viktoria Wieske  1 Stephan Achenbach  54 Matthew J Budoff  55 Michael Laule  1 David E Newby  56 Marc Dewey  57 COME-CCT Consortium
Affiliations
Meta-Analysis

Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data

Robert Haase et al. BMJ. .

Abstract

Objective: To determine whether coronary computed tomography angiography (CTA) should be performed in patients with any clinical probability of coronary artery disease (CAD), and whether the diagnostic performance differs between subgroups of patients.

Design: Prospectively designed meta-analysis of individual patient data from prospective diagnostic accuracy studies.

Data sources: Medline, Embase, and Web of Science for published studies. Unpublished studies were identified via direct contact with participating investigators.

Eligibility criteria for selecting studies: Prospective diagnostic accuracy studies that compared coronary CTA with coronary angiography as the reference standard, using at least a 50% diameter reduction as a cutoff value for obstructive CAD. All patients needed to have a clinical indication for coronary angiography due to suspected CAD, and both tests had to be performed in all patients. Results had to be provided using 2×2 or 3×2 cross tabulations for the comparison of CTA with coronary angiography. Primary outcomes were the positive and negative predictive values of CTA as a function of clinical pretest probability of obstructive CAD, analysed by a generalised linear mixed model; calculations were performed including and excluding non-diagnostic CTA results. The no-treat/treat threshold model was used to determine the range of appropriate pretest probabilities for CTA. The threshold model was based on obtained post-test probabilities of less than 15% in case of negative CTA and above 50% in case of positive CTA. Sex, angina pectoris type, age, and number of computed tomography detector rows were used as clinical variables to analyse the diagnostic performance in relevant subgroups.

Results: Individual patient data from 5332 patients from 65 prospective diagnostic accuracy studies were retrieved. For a pretest probability range of 7-67%, the treat threshold of more than 50% and the no-treat threshold of less than 15% post-test probability were obtained using CTA. At a pretest probability of 7%, the positive predictive value of CTA was 50.9% (95% confidence interval 43.3% to 57.7%) and the negative predictive value of CTA was 97.8% (96.4% to 98.7%); corresponding values at a pretest probability of 67% were 82.7% (78.3% to 86.2%) and 85.0% (80.2% to 88.9%), respectively. The overall sensitivity of CTA was 95.2% (92.6% to 96.9%) and the specificity was 79.2% (74.9% to 82.9%). CTA using more than 64 detector rows was associated with a higher empirical sensitivity than CTA using up to 64 rows (93.4% v 86.5%, P=0.002) and specificity (84.4% v 72.6%, P<0.001). The area under the receiver-operating-characteristic curve for CTA was 0.897 (0.889 to 0.906), and the diagnostic performance of CTA was slightly lower in women than in with men (area under the curve 0.874 (0.858 to 0.890) v 0.907 (0.897 to 0.916), P<0.001). The diagnostic performance of CTA was slightly lower in patients older than 75 (0.864 (0.834 to 0.894), P=0.018 v all other age groups) and was not significantly influenced by angina pectoris type (typical angina 0.895 (0.873 to 0.917), atypical angina 0.898 (0.884 to 0.913), non-anginal chest pain 0.884 (0.870 to 0.899), other chest discomfort 0.915 (0.897 to 0.934)).

Conclusions: In a no-treat/treat threshold model, the diagnosis of obstructive CAD using coronary CTA in patients with stable chest pain was most accurate when the clinical pretest probability was between 7% and 67%. Performance of CTA was not influenced by the angina pectoris type and was slightly higher in men and lower in older patients.

Systematic review registration: PROSPERO CRD42012002780.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: PS and MD had support from the joint programme of the German Research Foundation and the German Federal Ministry of Education and Research for the submitted work; PS has support from the German Research Foundation, grants from the European Union and grants from Bayer Pharma AG; GP reports grants from General Electric and is on the speakers bureau for Medtronic and Bracco; JH is on the speakers bureau for Abbott Vascular and Edwards Life Sciences; BG reports that the Cliniques St Luc UCL holds a master research agreement with Philips Medical Systems; UJS reports institutional grants, personal fees, and non-financial support from Astellas, Bayer, General Electric, Guerbet, HeartFlow, and Siemens; BLN reports grants from Siemens and HeartFlow, JKreports grants from CardiRad and personal fees from GE Healthcare; RRB reports that the University Hospital Zurich holds a research agreement with GE Healthcare; MYC reports an institutional research agreement with Canon Medical, formerly Toshiba Medical (no financial support/funding); DAH reports institutional support from Philips Healthcare during the conduct of the primary study; BH-M reports that the University Hospital Zurich holds a research agreement with GE Healthcare; BJC reports grants from CV Diagnostix and non-financial support from TeraRecon during the conduct of the study; PAK reports that the University Hospital Zurich holds a research agreement with GE Healthcare; KFK reports grants from Toshiba Medical Corporation, grants from the Danish Heart Foundation, grants from AP Møller og hustru Chastine McKinney Møllers Fond, and grants from the Danish Agency for Science, Technology and Innovation by the Danish Council for Strategic Research; AA-Z reports grants and non-financial support from Toshiba Medical Systems; JH reports grants from Toshiba Medical Systems during the conduct of the study; AS reports personal fees from General Electric and Toshiba; NP is on the speakers bureau for Toshiba Medical Systems and reports grants from Toshiba Medical Systems; GMS reports grants from the German Federal Ministry of Education and Research (BMBF), during the conduct of the study; DEN reports grants from Toshiba Medical Systems; MD is supported by the FP7 programme of the European Commission for the randomised multicentre DISCHARGE trial (603266-2, HEALTH-2012.2.4.-2) from the Heisenberg programme of the German Research Foundation (DE 1361/14-1), and the Digital Health Accelerator of the Berlin Institute of Health, has received lecture fees from Canon Medical Systems, Guerbet, Cardiac MR Academy Berlin, and Bayer, is the editor of Cardiac CT (Springer), and offers hands-on workshops on cardiac CT imaging (http://herz-kurs.de/); Charité institutional master research agreements exist with Siemens Medical Solutions, General Electric, Philips Medical Systems, and Canon Medical Systems, and the terms of these arrangements are managed by the legal department of Charité - Universitätsmedizin Berlin.

Figures

Fig 1
Fig 1
PRISMA individual patient data (IPD) flow diagram. A total of 9598 studies were scanned after removing duplicates. After full text review of 580 publications, 154 studies remained for which IPD were sought. IPD were retrieved for 76 studies including 7813 participants. For this analysis, 2481 participants of 11 studies had to be excluded, mainly because angina pectoris type was not classified or other data for pretest probability (PTP) calculation were missing (1610). Further reasons for exclusion of participants from the main analysis included coronary stents or bypass grafts, unstable angina pectoris, and non-diagnostic, invasive, coronary angiography examinations. A total of 5332 patients were included in this IPD analysis. ICA=invasive coronary angiography
Fig 2
Fig 2
Clinical diagnostic performance of computed tomography angiography to diagnose obstructive coronary artery disease as a function of pretest probability. The x axis represents the predicted clinical pretest probability, and the y axis shows the post-test probabilities and thus the positive predictive value (PV) and 1−negative PV with their 95% confidence intervals, based on the generalised linear mixed model including non-diagnostic CTA examinations. Results for the generalised linear mixed model excluding non-diagnostic CTA examinations are shown in supplementary figure 3 in web appendix 2. Disease probabilities were predicted by averaging over the random effects distribution. AUC=area under the curve
Fig 3
Fig 3
Receiver operating characteristic curves of computed tomography angiography for obstructive coronary artery disease, by subgroup and after excluding non-diagnostic examinations (NDX). Diagnostic performance results are shown for all patients versus results obtained after exclusion of non-diagnostic test results. The inclusion of all patients (top left panel) resulted in lower performance, which is a more accurate prediction of the real world performance to be expected. Thus, all subgroup comparisons in the other three panels are provided for all patients (including non-diagnostic examinations): diagnostic performance was higher in men and lower in patients older than 75, and angina pectoris types were not significantly associated with performance. Curves were generated by a generalised linear mixed model and predictions based on these models. Computations were performed with the statistical package R and packages lme4 and pROC. Areas under the curve were constructed by use of the observed data and model based predictions, which also included the random effects reflecting variability between studies and unobserved influential variables
Fig 4
Fig 4
Summary receiver operating characteristic (SROC) curves for studies using computed tomography angiography to diagnose obstructive coronary artery disease, with and without individual participant data (IPD) available. Curves are shown for studies with IPD available versus studies for which no IPD were available. Curves were calculated by aggregated data methodology (SROC curves) both for panels and after excluding non-diagnostic test results, which were not consistently available in publications of studies that did not provide IPD. Of 76 studies that provided IPD, aggregate data were not available for seven studies (two unpublished), leaving 69 for the analysis of studies with IPD; of 78 studies that did not provide IPD, 76 had aggregate data available (fig 1); there was no significant difference in diagnostic performance between these two groups of diagnostic accuracy studies (P=0.73). Further details shown in table 4. For study number details, see supplementary figure 8. AUC=area under the curve

References

    1. Diamond GA, Denton TA, Berman DS, Cohen I. Prior restraint: a Bayesian perspective on the optimization of technology utilization for diagnosis of coronary artery disease. Am J Cardiol 1995;76:82-6. 10.1016/S0002-9149(99)80809-1 - DOI - PubMed
    1. Leeflang MM, Bossuyt PM, Irwig L. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J Clin Epidemiol 2009;62:5-12. 10.1016/j.jclinepi.2008.04.007 - DOI - PubMed
    1. Montalescot G, Sechtem U, Achenbach S, et al. Task Force Members. ESC Committee for Practice Guidelines. Document Reviewers 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003. 10.1093/eurheartj/eht296 - DOI - PubMed
    1. National Institute for Health and Care Excellence. Chest pain of recent onset: assessment and diagnosis. Secondary chest pain of recent onset: assessment and diagnosis 2016. https://www.nice.org.uk/guidance/cg95. - PubMed
    1. Moschovitis A, Cook S, Meier B. Percutaneous coronary interventions in Europe in 2006. EuroIntervention 2010;6:189-94. 10.4244/EIJV6I2A31 - DOI - PubMed

Publication types

MeSH terms